Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial
暂无分享,去创建一个
F. Baron | G. Fillet | L. Seidel | Y. Beguin | C. Bonnet | K. Hafraoui | A. Gothot | E. Baudoux | É. Willems | C. Herens | G. Vanstraelen | P. Frère | N. Wanten | Jf. Vanbellinghen
[1] F. Baron,et al. Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning , 2008, Haematologica.
[2] M. Maris,et al. Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. , 2007, Blood.
[3] F. Baron,et al. Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning , 2006, Leukemia.
[4] S. Heimfeld,et al. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation , 2005, Leukemia.
[5] S. Heimfeld,et al. Allogeneic peripheral blood stem cell graft composition affects early T‐cell chimaerism and later clinical outcomes after non‐myeloablative conditioning , 2005, British journal of haematology.
[6] M. Sorror,et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning , 2004 .
[7] M. Talpaz,et al. Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[8] T. Reichert,et al. SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT‐VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL , 1994, Transplantation.